Logo image of ALTS

ALT5 SIGMA CORP (ALTS) Stock Overview

NASDAQ:ALTS - US47089W1045 - Common Stock

7.88 USD
-0.47 (-5.63%)
Last: 8/29/2025, 8:06:11 PM
7.91 USD
+0.03 (+0.38%)
After Hours: 8/29/2025, 8:06:11 PM

ALTS Key Statistics, Chart & Performance

Key Statistics
52 Week High10.95
52 Week Low1.55
Market Cap966.17M
Shares122.61M
Float108.96M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO02-22 2006-02-22
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ALTS short term performance overview.The bars show the price performance of ALTS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

ALTS long term performance overview.The bars show the price performance of ALTS in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of ALTS is 7.88 USD. In the past month the price increased by 25.48%. In the past year, price increased by 226.97%.

ALT5 SIGMA CORP / ALTS Daily stock chart

ALTS Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.36 693.36B
JNJ JOHNSON & JOHNSON 17.72 426.69B
NVO NOVO-NORDISK A/S-SPONS ADR 14.48 250.88B
AZN ASTRAZENECA PLC-SPONS ADR 18 247.73B
NVS NOVARTIS AG-SPONSORED ADR 14.3 244.98B
MRK MERCK & CO. INC. 10.92 210.11B
PFE PFIZER INC 7.3 140.77B
SNY SANOFI-ADR 11.17 120.68B
BMY BRISTOL-MYERS SQUIBB CO 7.01 96.03B
GSK GSK PLC-SPON ADR 8.8 79.92B
ZTS ZOETIS INC 25.14 69.31B
TAK TAKEDA PHARMACEUTIC-SP ADR 51.69 47.34B

About ALTS

Company Profile

ALTS logo image ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 10 full-time employees. The company went IPO on 2006-02-22. The Company, through its subsidiary, ALT5 Sigma, Inc., provides blockchain-powered technologies to enable migration to a global financial paradigm. The company offers two platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. The firm also owns Mswipe, which is a payment solutions provider offering multi-currency, fiat payment card services along with crypto-enabled capabilities.

Company Info

ALT5 SIGMA CORP

325 E Warm Springs Rd Ste 102

Las Vegas NEVADA US

Employees: 10

ALTS Company Website

ALTS Investor Relations

Phone: 17029975968

ALT5 SIGMA CORP / ALTS FAQ

What is the stock price of ALT5 SIGMA CORP today?

The current stock price of ALTS is 7.88 USD. The price decreased by -5.63% in the last trading session.


What is the ticker symbol for ALT5 SIGMA CORP stock?

The exchange symbol of ALT5 SIGMA CORP is ALTS and it is listed on the Nasdaq exchange.


On which exchange is ALTS stock listed?

ALTS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ALT5 SIGMA CORP stock?

7 analysts have analysed ALTS and the average price target is 24.48 USD. This implies a price increase of 210.66% is expected in the next year compared to the current price of 7.88. Check the ALT5 SIGMA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ALT5 SIGMA CORP worth?

ALT5 SIGMA CORP (ALTS) has a market capitalization of 966.17M USD. This makes ALTS a Small Cap stock.


How many employees does ALT5 SIGMA CORP have?

ALT5 SIGMA CORP (ALTS) currently has 10 employees.


What are the support and resistance levels for ALT5 SIGMA CORP (ALTS) stock?

ALT5 SIGMA CORP (ALTS) has a support level at 5.64 and a resistance level at 8.46. Check the full technical report for a detailed analysis of ALTS support and resistance levels.


Is ALT5 SIGMA CORP (ALTS) expected to grow?

The Revenue of ALT5 SIGMA CORP (ALTS) is expected to grow by 205.43% in the next year. Check the estimates tab for more information on the ALTS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ALT5 SIGMA CORP (ALTS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALT5 SIGMA CORP (ALTS) stock pay dividends?

ALTS does not pay a dividend.


When does ALT5 SIGMA CORP (ALTS) report earnings?

ALT5 SIGMA CORP (ALTS) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of ALT5 SIGMA CORP (ALTS)?

ALT5 SIGMA CORP (ALTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1).


What is the Short Interest ratio of ALT5 SIGMA CORP (ALTS) stock?

The outstanding short interest for ALT5 SIGMA CORP (ALTS) is 5.55% of its float. Check the ownership tab for more information on the ALTS short interest.


ALTS Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to ALTS. When comparing the yearly performance of all stocks, ALTS is one of the better performing stocks in the market, outperforming 96.84% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALTS Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ALTS. ALTS has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALTS Financial Highlights

Over the last trailing twelve months ALTS reported a non-GAAP Earnings per Share(EPS) of -1. The EPS increased by 74.35% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -17.6%
ROE -55.73%
Debt/Equity 0.76
Chartmill High Growth Momentum
EPS Q2Q%-799%
Sales Q2Q%194.05%
EPS 1Y (TTM)74.35%
Revenue 1Y (TTM)926.05%

ALTS Forecast & Estimates

7 analysts have analysed ALTS and the average price target is 24.48 USD. This implies a price increase of 210.66% is expected in the next year compared to the current price of 7.88.

For the next year, analysts expect an EPS growth of -87.54% and a revenue growth 205.43% for ALTS


Analysts
Analysts82.86
Price Target24.48 (210.66%)
EPS Next Y-87.54%
Revenue Next Year205.43%

ALTS Ownership

Ownership
Inst Owners7.96%
Ins Owners4.19%
Short Float %5.55%
Short Ratio0.26